These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22843491)

  • 21. Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.
    Rosenzwajg M; Churlaud G; Mallone R; Six A; Dérian N; Chaara W; Lorenzon R; Long SA; Buckner JH; Afonso G; Pham HP; Hartemann A; Yu A; Pugliese A; Malek TR; Klatzmann D
    J Autoimmun; 2015 Apr; 58():48-58. PubMed ID: 25634360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study.
    Rosenzwajg M; Salet R; Lorenzon R; Tchitchek N; Roux A; Bernard C; Carel JC; Storey C; Polak M; Beltrand J; Amouyal C; Hartemann A; Corbeau P; Vicaut E; Bibal C; Bougnères P; Tran TA; Klatzmann D
    Diabetologia; 2020 Sep; 63(9):1808-1821. PubMed ID: 32607749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes.
    Li CR; Mueller EE; Bradley LM
    Immunol Lett; 2015 Feb; 163(2):199-205. PubMed ID: 25447401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study.
    Truman LA; Pekalski ML; Kareclas P; Evangelou M; Walker NM; Howlett J; Mander AP; Kennet J; Wicker LS; Bond S; Todd JA; Waldron-Lynch F
    BMJ Open; 2015 Dec; 5(12):e009799. PubMed ID: 26646829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
    Li CR; Deiro MF; Godebu E; Bradley LM
    J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
    Visperas A; Vignali DA
    J Immunol; 2016 Nov; 197(10):3762-3770. PubMed ID: 27815439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
    Schneider A; Rieck M; Sanda S; Pihoker C; Greenbaum C; Buckner JH
    J Immunol; 2008 Nov; 181(10):7350-5. PubMed ID: 18981158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation.
    Marfil-Garza BA; Hefler J; Bermudez De Leon M; Pawlick R; Dadheech N; Shapiro AMJ
    Endocr Rev; 2021 Mar; 42(2):198-218. PubMed ID: 33247733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptive immune regulation in autoimmune diabetes.
    Ferretti C; La Cava A
    Autoimmun Rev; 2016 Mar; 15(3):236-41. PubMed ID: 26631820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical application of regulatory T cells in type 1 diabetes.
    Marek-Trzonkowska N; Myśliwec M; Siebert J; Trzonkowski P
    Pediatr Diabetes; 2013 Aug; 14(5):322-32. PubMed ID: 23627860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-35 administration counteracts established murine type 1 diabetes--possible involvement of regulatory T cells.
    Singh K; Kadesjö E; Lindroos J; Hjort M; Lundberg M; Espes D; Carlsson PO; Sandler S; Thorvaldson L
    Sci Rep; 2015 Jul; 5():12633. PubMed ID: 26224624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulation of antigen presenting cells promotes natural regulatory T cells that prevent autoimmune diabetes in NOD mice.
    Richer MJ; Lavallée DJ; Shanina I; Horwitz MS
    PLoS One; 2012; 7(2):e31153. PubMed ID: 22355341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of type 1 diabetes by regulatory T-cell infusion via regulating the expression of inflammatory cytokines.
    Wang G; Yan Y; Xu N; Yin D; Hui Y
    J Cell Biochem; 2019 Dec; 120(12):19338-19344. PubMed ID: 31535398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.
    Haque M; Das JK; Xiong X; Song J
    Curr Diab Rep; 2019 Aug; 19(10):89. PubMed ID: 31471667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cells.
    Vercoulen Y; Wehrens EJ; van Teijlingen NH; de Jager W; Beekman JM; Prakken BJ
    PLoS One; 2009 Sep; 4(9):e7183. PubMed ID: 19779623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes.
    Rabinovitch A; Suarez-Pinzon WL
    Cell Biochem Biophys; 2007; 48(2-3):159-63. PubMed ID: 17709885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.